Phone Number : +86 13989889852
WhatsApp : +008613989889852
October 25, 2021
Recently, ALLTEST COVID-19 Antigen Rapid Test (Oral Fluid) successfully passed the performance verification of the Paul Ehrlich Institute PEI (German: Paul-Ehrlich-Institut) in Germany. The product was listed by BfArm in Germany last year. This means that ALLTEST COVID-19 Antigen Rapid Test (Oral Fluid) has passed the European test with the highest gold content and recognition, and successfully entered the German market!
Prior to this, the product has obtained the European Union CE, Indonesia, Russia, Italy, Romania, Estonia and other countries and regions access qualifications, and has contributed to the global prevention and control of the COVID-19 epidemic.
PEI: German Paul Ehrlich Institute (German: Paul-Ehrlich-Institut), also known as the German Federal Institute of Vaccines and Biomedical Research, is a research institution and medical regulatory agency of the German Federation, currently under the Federal Ministry of Health (BMG) , Has the independent performance of biological product inspection, clinical trial approval, product approval and marketing and batch issuance functions, and also undertakes to provide scientific research for the drafting and revision of relevant laws and regulations of different organizations, especially some European Union countries, European Union and international committees Suggestions, and also provide professional advice to the German government, local agencies and parliament, and provide relevant information to patients and consumers.
BfArm: BfArm (Bundesinstitut für Arzneimittel und Medizinprodukte) is the German Federal Agency for Medicines and Medical Devices, which supervises all chemicals, botanicals and auxiliary drugs.
This performance verification is another affirmation of the quality of ALLTEST products. At present, the global epidemic prevention and control work has achieved initial results. However, in the continuing epidemic era, ALLTEST continues to show the world the brand strength of independent research and development, innovation and development. Continuously optimize the new crown epidemic solution, and contribute to the global fight against the epidemic!